HUP0102116A2 - Paroxetine ascorbate, process for its preparation and its pharmaceutical use - Google Patents
Paroxetine ascorbate, process for its preparation and its pharmaceutical useInfo
- Publication number
- HUP0102116A2 HUP0102116A2 HU0102116A HUP0102116A HUP0102116A2 HU P0102116 A2 HUP0102116 A2 HU P0102116A2 HU 0102116 A HU0102116 A HU 0102116A HU P0102116 A HUP0102116 A HU P0102116A HU P0102116 A2 HUP0102116 A2 HU P0102116A2
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- pharmaceutical use
- paroxetine ascorbate
- paroxetine
- ascorbate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány egyik tárgyát paroxetin-aszkorbát képezi. A találmánykiterjed a paroxetin-aszkorbát előállítási eljárására és alkalmazásárakülönféle ggyógyászati rendellenességek kezelé- sében. ÓOne object of the invention is paroxetine ascorbate. The invention extends to the production process and application of paroxetine ascorbate in the treatment of various medical disorders. HE
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0102116A2 true HUP0102116A2 (en) | 2002-05-29 |
| HUP0102116A3 HUP0102116A3 (en) | 2002-12-28 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102116A HUP0102116A3 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate, process for its preparation and its pharmaceutical use |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (en) |
| JP (1) | JP2002513019A (en) |
| KR (1) | KR20010042977A (en) |
| CN (1) | CN1297448A (en) |
| AP (1) | AP2000001963A0 (en) |
| AU (1) | AU3618499A (en) |
| BG (1) | BG104940A (en) |
| BR (1) | BR9909868A (en) |
| CA (1) | CA2330055A1 (en) |
| EA (1) | EA200001104A1 (en) |
| GB (1) | GB9808896D0 (en) |
| HU (1) | HUP0102116A3 (en) |
| ID (2) | ID26654A (en) |
| IL (1) | IL139081A0 (en) |
| NO (1) | NO20005352D0 (en) |
| PL (1) | PL343677A1 (en) |
| SK (1) | SK15912000A3 (en) |
| TR (1) | TR200003084T2 (en) |
| WO (1) | WO1999055698A1 (en) |
| ZA (1) | ZA200005912B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| US7227033B2 (en) | 2002-01-09 | 2007-06-05 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| CN118267895A (en) * | 2018-10-30 | 2024-07-02 | 中国科学院化学研究所 | Method for preparing drug or drug intermediate amorphous material |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (en) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (en) * | 1996-02-29 | 1999-07-01 | Ferrer Int | NEW PROCEDURE FOR OBTAINING (-) - TRANS -N-P-FLUOROBENZOILMETIL-4- (P-FLUOROFENIL) -3- ((3,4- (METHYLENDIOXI) PHENOXI) METHYL) -PIPERIDINE. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/en not_active Application Discontinuation
- 1999-04-23 EA EA200001104A patent/EA200001104A1/en unknown
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/en unknown
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/en not_active Application Discontinuation
- 1999-04-23 ID IDW20002169A patent/ID26654A/en unknown
- 1999-04-23 IL IL13908199A patent/IL139081A0/en unknown
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 CN CN99805160A patent/CN1297448A/en active Pending
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Application Discontinuation
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/en unknown
- 1999-04-23 ID IDW20002168A patent/ID26083A/en unknown
- 1999-04-23 PL PL99343677A patent/PL343677A1/en not_active Application Discontinuation
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/en unknown
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/en active Pending
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352D0/en not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR200003084T2 (en) | 2001-02-21 |
| PL343677A1 (en) | 2001-08-27 |
| CA2330055A1 (en) | 1999-11-04 |
| KR20010042977A (en) | 2001-05-25 |
| EP1089995A1 (en) | 2001-04-11 |
| SK15912000A3 (en) | 2001-04-09 |
| BG104940A (en) | 2001-09-28 |
| IL139081A0 (en) | 2001-11-25 |
| HUP0102116A3 (en) | 2002-12-28 |
| AP2000001963A0 (en) | 2000-12-31 |
| JP2002513019A (en) | 2002-05-08 |
| AU3618499A (en) | 1999-11-16 |
| NO20005352L (en) | 2000-10-24 |
| ZA200005912B (en) | 2001-12-19 |
| BR9909868A (en) | 2000-12-19 |
| ID26083A (en) | 2000-11-23 |
| GB9808896D0 (en) | 1998-06-24 |
| WO1999055698A1 (en) | 1999-11-04 |
| EA200001104A1 (en) | 2001-04-23 |
| ID26654A (en) | 2001-01-25 |
| CN1297448A (en) | 2001-05-30 |
| NO20005352D0 (en) | 2000-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301868A2 (en) | Pharmaceutical composition comprising a factor viia and a factor xiii | |
| HUP9903905A2 (en) | Combination therapy for treatment of psychoses | |
| NO20061736L (en) | Crystal form of epothilone B | |
| IL154888A (en) | Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis | |
| MY127980A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
| HUP0302114A2 (en) | Liquid medicinal preparation containing erythropoietin protein, method for production and application | |
| HUP0104709A2 (en) | Use of erythropoietin or erythropoietin derivatives for the manufacture of a medicament for treatment of cerebral ischaemia | |
| HUP0303082A2 (en) | Substituted indoleoxoacetic piperazine derivatives, pharmaceutical compositions containing them and their antiviral use | |
| DE50305587D1 (en) | 2-heteroarylcarbonsäureamide | |
| PL366800A1 (en) | Tablet comprising cetirizine and pseudoephedrine | |
| BR0008292A (en) | Mevinoline derivatives | |
| HUP9700806A2 (en) | Matrix tablet allowing the prolonged release of the sodium salt of tianeptine and process for the preparation thereof | |
| HUP0100080A2 (en) | Use of mirtazapine for producing pharmaceutical compositions for treating sleep apneas | |
| DE59904180D1 (en) | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | |
| DE60115054D1 (en) | PHARMACEUTICAL COMPOSITION THE TRKAIG2 CONTAINS FOR USE IN THE PREVENTION AND / OR TREATMENT OF CANCER | |
| MY129643A (en) | Tablet comprising cetirizine and pseudoephedrine | |
| TR200202488T2 (en) | Device and method for producing high-function water and water containing titanium | |
| BR9814945A (en) | Use of phanquinone for the treatment of alzheimer's disease, pharmaceutical composition and kit | |
| HUP0103712A2 (en) | Salts of paroxetine, process for their preparation and their pharmaceutical use | |
| TR200200278T2 (en) | Calcilitic compositions | |
| DE60213234D1 (en) | 4- (PENYLPIPERIDIN-4-YLIDENETHYL) BENZAMID DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PAIN, FEAR STORIES OR DISEASES OF THE STOMACH DARM TRAKTS | |
| HUP0102116A2 (en) | Paroxetine ascorbate, process for its preparation and its pharmaceutical use | |
| HUP0200145A2 (en) | Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies | |
| HUP0001913A2 (en) | Use of pramipexole for the preparation of pharmaceutical compositions treating restless legs syndrome | |
| TR199901385T2 (en) | Piperidin t�revleri. |